Altria Group, Inc. MO

NYSE · Consumer Defensive · Tobacco

$74.87

Close on Fri, 20 Nov 2026 · market value $125B

What the price is betting on

Below its record

At $75, the price assumes revenue shrinks about 5.6% a year for five years, from $21.3B to about $16.6B by FY2030. That is about the same as what analysts expect for the next two years and less than the company's own last three years.

The price assumes−5.6%
Analysts, next two years−0.1%
Last 3 years1.4%

Revenue growth a year. The price figure comes from a reverse DCF at a 7.2% discount rate.

Track it and Parra checks each report against the path, and tells you when revenue falls behind it.

Own more than MO? Check up to 5 of your stocks at once, free, no account.

0$10B$20B$30B$21.3B'22'23'24'25Sep '26'26'27'28'29'30What the price needsReportedAnalysts

Both sides

Three stories, three values

Bear

$98

Base

$110

Bull

$124

Today $75

  • Bear $98. Cash flow grows -1% a year for the next 5 years, slower than expected, then slows to long-run growth.
  • Base $110. Cash flow grows 1% a year for the next 5 years, as analysts expect, then slows to long-run growth.
  • Bull $124. Cash flow grows 3% a year for the next 5 years, faster than expected, then slows to long-run growth.

Stories set by rules from the company’s record.

Checkpoints

The revenue the price needs

  1. YearNeedsAnalysts expect
  2. FY2026$21B$20.7B, on the path
  3. FY2027$19.8B$20.9B, on the path
  4. FY2028$18.7B$21.4B, on the path
  5. FY2029$17.6B$22B, on the path
  6. FY2030$16.6B$22.8B, on the path

Each year's revenue at −5.6% growth from $21.3B in the 12 months to September 2026.

At a glance

Consumer Defensive · Tobacco · listed on NYSE

Revenue, FY2025
$20.1B
Growth, 3 years a year
1.4%
Cash margin
45%
Net debt
$21.2B
Shares, 3-year change
−6.4%
Dividend yield
5.6%

What other consumer defensive prices are betting on

Figures from company filings and end-of-day market data, as of the close on Fri, 20 Nov 2026; updated every trading day. This page shows what today's price assumes, not whether to buy or sell. Not investment advice.